Lucas Vitale - 03 Mar 2026 Form 4 Insider Report for Orthofix Medical Inc. (OFIX)

Reporting relationship: CP&BOO
Issuer ticker: OFIX
Reported as of: 03 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2026, 18:49:35 UTC
Prior SEC filing: 20 Mar 2025
Next SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ J. Andres Cedron, Attorney-in-fact

Key filing fact

Lucas Vitale filed Form 4 for Orthofix Medical Inc. (OFIX) on 05 Mar 2026.

Key facts

This page summarizes Lucas Vitale's Form 4 filing for Orthofix Medical Inc. (OFIX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2026, 18:49.

Change

Previous filing in this sequence was filed on 20 Mar 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001763869 Primary reporting owner

Vitale Lucas

Relationship: CP&BOO
Address: 3451 PLANO PARKWAY, LEWISVILLE
Signature: /s/ J. Andres Cedron, Attorney-in-fact
Signature date: 05 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OFIX transaction

Common Stock

Award

Transaction value
Shares: +19,186
Change %: +13%
Price: $0.000000^*
Shares after: 167,030
Date: 03 Mar 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OFIX transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value
Shares: +45,546
Change %
Price: $0.000000^*
Shares after: 45,546
Date: 03 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 45,546
Exercise price: $13.03
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents a grant of restricted stock units approved by the Compensation and Talent Development Committee of the Company's Board of Directors (the administrator of the plan pursuant to which such restricted stock units were granted). The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered thereby on the first, second and third anniversary of the Grant Date.

Footnote F2

Includes 123,894 previously reported restricted stock units and an aggregate of 12,527 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 04/30/2025 and 10/31/2025. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).

Footnote F3

The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first, second and third anniversary of the Grant Date.